Shionogi to Focus on Safety, Not Sales, in Detailing Xofluza

Shionogi President Isao Teshirogi Shionogi will not set Xofluza (baloxavir marboxil) sales goals for its drug reps in the current fiscal year in order to focus on providing safety-related information in detailing the anti-influenza drug, President Isao Teshirogi said on...read more